Pharmaceutical Investing Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA® in Certain Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone's Vaccine Platform Technology for HIV Cure
Pharmaceutical Investing Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating KEYTRUDA® in Combination With Ipilimumab Versus KEYTRUDA Monotherapy in Certain Patients With Metastatic Non-Small Cell Lung Cancer
Medical Device Investing Medtronic Receives FDA Approval of DiamondTemp Ablation System for the Treatment of Patients with Atrial Fibrillation
Medical Device Investing Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
Medical Device Investing Thermo Fisher Scientific Named "Best Place to Work for LGBTQ Equality" for Sixth Consecutive Year
Radiopharm Theranostics Doses First Patient with 18F-RAD101 in U.S. Phase 2b Imaging Study of Brain MetastasisÂ
